NATR NATURES SUNSHINE PRODUCTS INC

$20.05 -0.12%

Healthcare · Pharmaceutical Preparations

NATURES SUNSHINE PRODUCTS INC (NATR) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $352 million. Shares last traded at $20.05, 28.6% below their 52-week high. Over the past year the stock is up 34.5%. NATR trades at a price-to-earnings ratio of 18.06, above the Pharmaceutical Preparations median of 16.82. Net profit margin is 4.1%, above the peer median of -0.1%. Revenue grew 5.7% year over year. The shares yield 5.0% in dividends.

Market Cap

$352M

Shares Out

17.6M

EPS (TTM)

$1.91

P/E Ratio

10.49

P/S Ratio

0.73

P/B Ratio

2.11

Dividend / Share

$1.00

Dividend Yield

4.99%

52-Week High

$28.08

52-Week Low

$13.00

Volume

4,373

Avg Vol (3m)

3,612.651

Performance

-1.91%

-7.20%

-16.37%

-10.39%

YTD

-4.68%

+34.53%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

31.37

SMA (50)

$23.50

SMA (200)

$21.59

Price vs SMA50

-14.69%

Price vs SMA200

-7.14%

ATR (14)

$1.02

Financials

Revenue

$480M

Net Income

$20M

Gross Margin

72.4%

Operating Margin

5.2%

Net Margin

4.1%

Return on Equity

11.7%

Return on Assets

7.5%

Current Ratio

2.50

Debt / Equity

0.01

Revenue Growth (YoY)

+5.7%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$0.29	2026-05-07
FY 2025	$1.06	2026-03-10
Q3 2025	$0.83	2025-11-06
Q2 2025	$0.54	2025-07-31
Q1 2026	$0.25	2026-05-07
FY 2025	$0.40	2026-03-10

Full earnings history →

Pharmaceutical Preparations peers

NATR vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

18.06 / 16.82 med

+7% premium

P/S vs peers

0.73 / 3.54 med

-79% discount

Net margin vs peers

4.1% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.